Effects of Deoxynivalenol Consumption on Body Weight and Adiposity in the Diet-Induced Obese Mouse

REFERENCES

• Amuzie , C. J. and Pestka , J. J. 2010 . Suppression of insulin-like growth factor acid-labile subunit expression—A novel mechanism for deoxynivalenol-induced growth retardation . Toxicol. Sci. , 113 : 412 – 421 .
   PubMed Web of Science ®Google Scholar
• Amuzie , C. J. , Harkema , J. R. and Pestka , J. J. 2008 . Tissue distribution and proinflammatory cytokine induction by the trichothecene deoxynivalenol in the mouse: Comparison of nasal vs. oral exposure . Toxicology , 248 : 39 – 44 .
   PubMed Web of Science ®Google Scholar
• Amuzie , C. J. , Shinozuka , J. and Pestka , J. J. 2009 . Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse . Toxicol. Sci. , 111 : 277 – 287 .
   PubMed Web of Science ®Google Scholar
• Baur , J. A. , Pearson , K. J. , Price , N. L. , Jamieson , H. A. , Lerin , C. , Kalra , A. , Prabhu , V. V. , Allard , J. S. , Lopez-Lluch , G. , Lewis , K. , Pistell , P. J. , Poosala , S. , Becker , K. G. , Boss , O. , Gwinn , D. , Wang , M. , Ramaswamy , S. , Fishbein , K. W. , Spencer , R. G. , Lakatta , E. G. , Le , C. D. , Shaw , R. J. , Navas , P. , Puigserver , P. , Ingram , D. K. , de Cabo , R. and Sinclair , D. A. 2006 . Resveratrol improves health and survival of mice on a high-calorie diet . Nature , 444 : 337 – 342 .
   PubMed Web of Science ®Google Scholar
• Bray , G. A. 2008 . Lifestyle and pharmacological approaches to weight loss: Efficacy and safety . J. Clin. Endocrinol. Metab. , 93 : S81–S88
   Google Scholar
• Canady , R. A. , Coker , R. D. , Regan , S. K. , Krska , R. , Kuiper-Goodman , T. , Olsen , M. , Pestka , J. J. , Resnik , S. and Schlatter , J. 2001 . “ Deoxynivalenol ” . In Safety evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives , 420 – 555 . Geneva : International Programme on Chemical Safety. World Health Organization .
   Google Scholar
• Castillo , C. , Cruzado , M. , Ariznavarreta , C. , Gil-Loyzaga , P. , Lahera , V. , Cachofeiro , V. and Tresguerres , J. A. F. 2003 . Body composition and vascular effects of growth hormone administration in old female rats . Exp. Gerontol. , 38 : 971 – 979 .
   PubMed Web of Science ®Google Scholar
• Chen , Y. , Sun , D. , Krishnamurthy , V. M. and Rabkin , R. 2007 . Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding . Am. J. Physiol. Endocrinol. Metab. , 292 : E1856 – E1862 .
   Google Scholar
• Clifford , L. J. , Jia , Q. and Pestka , J. J. 2003 . An improved method for the purification of the trichothecene deoxynivalenol (vomitoxin) from Fusarium graminearum culture . J. Agric. Food Chem. , 51 : 521 – 523 .
   PubMed Web of Science ®Google Scholar
• Coccurello , R. , Caprioli , A. , Conti , R. , Ghirardi , O. , Borsini , F. , Carminati , P. and Ana Moles , A. 2008 . Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice . J. Pharmacol. Exp. Ther. , 326 : 905 – 911 .
   PubMed Web of Science ®Google Scholar
• De Benedetti , F. , Alonzi , T. , Moretta , A. , Lazzaro , D. , Costa , P. , Poli , V. , Martini , A. , Ciliberto , G. and Fattori , E. 1997 . Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation . J. Clin. Invest. , 99 : 643 – 650 .
   PubMed Web of Science ®Google Scholar
• Fioramonti , J. , Dupuy , C. , Dupuy , J. and Bueno , L. 1993 . The mycotoxin, deoxynivalenol, delays gastric emptying through serotonin-3 receptors in rodents . J. Pharmacol. Exp. Ther. , 266 : 1255 – 1260 .
   PubMed Web of Science ®Google Scholar
• Forsell , J. H. , Witt , M. F. , Tai , J. H. , Jensen , R. and Pestka , J. J. 1986 . Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone . Food Chem.Toxicol. , 24 : 213 – 219 .
   PubMed Web of Science ®Google Scholar
• Forsyth , D. M. , Yoshizawa , T. , Morooka , N. and Tuite , J. 1977 . Emetic and refusal activity of deoxynivalenol to swine . Appl. Environ. Microbiol. , 34 : 547 – 552 .
   PubMed Web of Science ®Google Scholar
• Gesta , S. , Tseng , Y. H. and Kahn , C. R. 2007 . Developmental origin of fat: tracking obesity to its source . Cell , 131 : 242 – 256 .
   PubMed Web of Science ®Google Scholar
• Grove , J. F. 2007 . The trichothecenes and their biosynthesis . Fortschr. Chem. Org. Naturst. , 88 : 63 – 130 .
   PubMedGoogle Scholar
• Halaas , J. L. , Boozer , C. , Blair-West , J. , Fidahusein , N. , Denton , D. A. and Friedman , J. M.. 1997 . Physiological response to long-term peripheral and central leptin infusion in lean and obese mice . Proc. Natl. Acad. Sci. USA , 94 : 8878 – 8883 .
   PubMed Web of Science ®Google Scholar
• Hirsch , J. and Batchelor , B. 1976 . Adipose tissue cellularity in human obesity . Clin. Endocrinol. Metab. , 5 : 299 – 311 .
   PubMedGoogle Scholar
• Hughes , D. M. , Gahl , M. J. , Graham , C. H. and Grieb , S. L. 1999 . Overt signs of toxicity to dogs and cats of dietary deoxynivalenol . J. Anim. Sci. , 77 : 693 – 700 .
   PubMed Web of Science ®Google Scholar
• Hunt , J. N. 1980 . A possible relation between the regulation of gastric emptying and food intake . Am. J. Physiol. , 239 : G1 – G4 .
   PubMed Web of Science ®Google Scholar
• Idelevich , E. , Kirch , W. and Schindler , C. 2009 . Current pharmacotherapeutic concepts for the treatment of obesity in adults . Ther. Adv. Cardiovasc. Dis. , 3 : 75 – 90 .
   PubMedGoogle Scholar
• Iverson , F. , Armstrong , C. , Nera , E. , Truelove , J. , Fernie , S. , Scott , P. , Stapley , R. , Hayward , S. and Gunner , S. 1995 . Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice . Teratogen. Carcinogen. Mutagen. , 15 : 283 – 306 .
   PubMedGoogle Scholar
• Johnson , M. S. , Thomson , S. C. and Speakman , J. R. 2001 . Limits to sustained energy intake: I. Lactation in the laboratory mouse Mus musculus . J. Exp. Biol. , 204 : 1925 – 1935 .
   PubMed Web of Science ®Google Scholar
• Krantis, A. C., and Durst, T. 2006. Novel multi-ring organic compounds for regulating gut motility, food intake and weight gain. World Intellectual Property Organization. WO/2006/006082 http://www.wipo.int/pctdblen/jsp?wo=2006006082 (http://www.wipo.int/pctdblen/jsp?wo=2006006082)
   Google Scholar
• Lang , C. H. , Hong-Brown , L. and Frost , R. A. 2005 . Cytokine inhibition of JAK-STAT signaling: A new mechanism of growth hormone resistance . Pediatr. Nephrol. , 20 : 306 – 312 .
   PubMed Web of Science ®Google Scholar
• le Roux , C. W. , Batterham , R. L. , Aylwin , S. J. , Patterson , M. , Borg , C. M. , Wynne , K. J. , Kent , A. , Vincent , R. P. , Gardiner , J. , Ghatei , M. A. and Bloom , S. R. 2006 . Attenuated peptide YY release in obese subjects is associated with reduced satiety . Endocrinology , 147 : 3 – 8 .
   PubMed Web of Science ®Google Scholar
• Li , Y. 2007 . Sensory signal transduction in the vagal primary afferent neurons . Curr. Med. Chem. , 14 : 2554 – 2563 .
   PubMed Web of Science ®Google Scholar
• Morrissey , R. E. and Vesonder , R. F. 1985 . Effect of deoxynivalenol (vomitoxin) on fertility, pregnancy, and postnatal-development of Sprague-Dawley rats . Appl. Environ. Microbiol. , 49 : 1062 – 1066 .
   PubMed Web of Science ®Google Scholar
• Muoio , D. M. and Newgard , C. B. 2006 . Obesity-related derangements in metabolic regulation . Annu. Rev. Biochem. , 75 : 367 – 401 .
   PubMed Web of Science ®Google Scholar
• Ok , H. E. , Kim , H. J. , Cho , T. Y. , Oh , K. S. and Chun , H. S. 2009 . Determination of deoxynivalenol in cereal-based foods and estimation of dietary exposure . J. Toxicol. Environ. Health A , 72 : 1424 – 1430 .
   PubMed Web of Science ®Google Scholar
• Pestka , J. J. and Smolinski , A. T. 2005 . Deoxynivalenol: Toxicology and potential effects on humans . J. Toxicol. Environ. Health B Crit. Rev. , 8 : 39 – 69 .
   PubMed Web of Science ®Google Scholar
• Pestka , J. J. and Zhou , H. R. 2002 . Effects of tumor necrosis factor type 1 and 2 receptor deficiencies on anorexia, growth and IgA dysregulation in mice exposed to the trichothecene vomitoxin . Food Chem. Toxicol. , 40 : 1623 – 1631 .
   PubMed Web of Science ®Google Scholar
• Pestka , J. J. , Zhou , H. R. , Moon , Y. and Chung , Y. J. 2004 . Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox . Toxicol. Lett. , 153 : 61 – 73 .
   PubMed Web of Science ®Google Scholar
• Prelusky , D. B. 1997 . Effect of intraperitoneal infusion of deoxynivalenol on feed consumption and weight gain in the pig . Nat. Toxins. , 5 : 121 – 125 .
   PubMedGoogle Scholar
• Prelusky , D. B. , Gerdes , R. G. , Underhill , K. L. , Rotter , B. A. , Jui , P. Y. and Trenholm , H. L. 1994 . Effects of low-level dietary deoxynivalenol on haematological and clinical parameters of the pig . Nat. Toxins. , 2 : 97 – 104 .
   PubMedGoogle Scholar
• Prelusky , D. B. and Trenholm , H. L. 1993 . The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine . Nat. Toxins. , 1 : 296 – 302 .
   PubMedGoogle Scholar
• Raghow , R. , Yellaturu , C. , Deng , X. , Park , E. A. and Elam , M. B. 2008 . SREBPs: The crossroads of physiological and pathological lipid homeostasis . Trends Endocrinol. Metab. , 19 : 65 – 73 .
   PubMed Web of Science ®Google Scholar
• Rolland-Cachera , M. F. , Deheeger , M. and Bellisle , F. 1999 . Increasing prevalence of obesity among 18-year-old males in Sweden: Evidence for early determinants . Acta. Paediatr. , 88 : 365 – 367 .
   PubMedGoogle Scholar
• Sebert , S. P. , Lecannu , G. , Kozlowski , F. , Siliart , B. , Bard , J. M. , Krempf , M. and Champ , M. M. 2005 . Childhood obesity and insulin resistance in a Yucatan mini-piglet model: Putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development . Int. J. Obes. (Lond.) , 29 : 324 – 333 .
   PubMed Web of Science ®Google Scholar
• Van Heek , M. , Compton , D. S. , France , C. F. , Tedesco , R. P. , Fawzi , A. B. , Graziano , M. P. , Sybertz , E. J. , Strader , C. D. and Davis , H. R. Jr. 1997 . Diet-induced obese mice develop peripheral, but not central, resistance to leptin . J. Clin. Invest. , 99 : 385390
   Web of Science ®Google Scholar
• Voss , K. A. 2010 . A new perspective on deoxynivalenol and growth suppression . Toxicol. Sci. , 113 : 281283
   Web of Science ®Google Scholar
• Yakar , S. , Sun , H. , Zhao , H. , Pennisi , P. , Toyoshima , Y. , Setser , J. , Stannard , B. , Scavo , L. and Leroith , D. 2005 . Metabolic effects of IGF-I deficiency: lessons from mouse models . Pediatr. Endocrinol. Rev. , 3 : 11 – 19 .
   PubMedGoogle Scholar